Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LY333334 in Japanese Patients With Osteoporosis

NCT00433160 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00433160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LY333334 in Japanese Patients With Osteoporosis
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
September 30, 2009
Enrollment
207 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis